CoChat

Stimulation of superoxide production increases fungicidal action of miconazole against Candida albicans biofilms

Open access
De Cremer, Kaat, De Brucker, Katrijn, Staes, Ines, Peeters, Annelies, Van den Driessche, Freija, Coenye, Tom, Cammue, Bruno P. A., Thevissen, Karin · 2016 · Scientific Reports

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index; 22 of the 51 sources its claims cite were checked for support.

Abstract

We performed a whole-transcriptome analysis of miconazole-treated Candida albicans biofilms, using RNA-sequencing. Our aim was to identify molecular pathways employed by biofilm cells of this pathogen to resist action of the commonly used antifungal miconazole. As expected, genes involved in sterol biosynthesis and genes encoding drug efflux pumps were highly induced in biofilm cells upon miconazole treatment. Other processes were affected as well, including the electron transport chain (ETC), of which eight components were transcriptionally downregulated. Within a diverse set of 17 inhibitors/inducers of the transcriptionally affected pathways, the ETC inhibitors acted most synergistically with miconazole against C. albicans biofilm cells. Synergy was not observed for planktonically growing C. albicans cultures or when biofilms were treated in oxygen-deprived conditions, pointing to a biofilm-specific oxygen-dependent tolerance mechanism. In line, a correlation between miconazole’s fungicidal action against C. albicans biofilm cells and the levels of superoxide radicals was observed and confirmed both genetically and pharmacologically using a triple superoxide dismutase mutant and a superoxide dismutase inhibitor N-N′-diethyldithiocarbamate, respectively. Consequently, ETC inhibitors that result in mitochondrial dysfunction and affect production of reactive oxygen species can increase miconazole’s fungicidal activity against C. albicans biofilm cells.

Overview

CoChat Summary

TL;DR

Whole-transcriptome RNA-seq of miconazole-treated *Candida albicans* biofilms showed downregulation of respiratory electron transport chain (ETC) components, and combining miconazole with ETC inhibitors or simvastatin increased superoxide production and fungicidal activity against biofilm cells. This synergy was biofilm-specific and oxygen-dependent, linking miconazole’s antibiofilm killing to superoxide radicals.

Key findings

  • RNA-seq identified 323 and 828 differentially expressed genes at 4 h and 24 h after 75 μM miconazole treatment, respectively. Induced genes included ergosterol biosynthesis genes, efflux pumps (*CDR2*, *orf19.4531*, *MDR1* at 24 h), and *SOD5* at 24 h; repressed genes at 24 h included eight ETC components (*COX6*, *COX9*, *CYT1*, *RIP1*, *QCR2*, *QCR7*, *QCR9*, *orf19.913.2*).
  • Among 17 tested inhibitors/inducers, five acted synergistically with miconazole against biofilms: simvastatin, pyrithione zinc, antimycin A, CCCP, and sodium azide. All five reduced the miconazole BEC50 at least 4.4-fold; antimycin A had FICI = 0.10 and at 3.125 μM reduced miconazole BEC50 almost 11-fold.
  • Cfu counting showed significant reductions with 125 μM miconazole plus 500 μM simvastatin (97%), 25 μM antimycin A (99%), 15.6 μM CCCP (87%), or 1.25 mM sodium azide (95%); antimycin A increased miconazole fungicidal capacity 26-fold (almost 2 log units). Pyrithione zinc plus miconazole did not reduce cfus further.
  • Miconazole (125 μM) caused a 3-fold increase in superoxide; miconazole plus 25 μM antimycin A caused a 28-fold increase compared with miconazole alone. Fold reduction in cfu correlated with fold increase in superoxide (Pearson r = 0.95; p = 0.0144). Anaerobic treatment abolished antimycin A–miconazole synergy, and a ΔΔΔ*sod4sod5sod6* mutant was hypersusceptible to miconazole; the Sod inhibitor DDC increased miconazole fungicidal activity.

Methods

  • *C. albicans* SC5314 biofilms were grown for 24 h in RPMI 1640, treated with 75 μM miconazole or mock (0.5% DMSO), and collected at 4 h and 24 h for RNA-seq. Libraries were sequenced on Illumina HiSeq2000; reads were mapped to SC5314_A21, and differential expression was analyzed with EdgeR (FDR 1%). qRT-PCR validated 16 genes (Pearson correlation = 0.97 with RNA-seq logFC).
  • Checkerboard assays with CTB metabolic activity determined FICI and BEC50 values; planktonic assays used MIC50. Cfu counting and dihydroethidium staining measured killing and superoxide, respectively. Anaerobic treatments used the Anoxomat Mark II System. A triple superoxide dismutase mutant and the inhibitor DDC were used to confirm the superoxide link.

Limitations

  • The paper states that CTB metabolic activity assays can be confounded by ETC inhibitors, so controls comparing miconazole + ETC inhibitor versus ETC inhibitor alone were required. It also states that not all differentially expressed genes/pathways could be targeted because only well-known and easily available compounds were selected, and that lack of combination effect could reflect either pathway irrelevance or poor compound penetration into biofilms.
  • The paper notes that statins’ systemic antifungal potential is debated due to low achievable blood concentrations and possible CYP-mediated interactions with azoles.
  • Evident from the text: the study is in vitro and largely based on *C. albicans* SC5314 biofilms, with no in vivo infection model; RNA-seq was performed at only two time points after miconazole treatment.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/srep27463

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Number of significant (overlapping) differentially expressed genes 4 h and 24 h after miconazole treatment. Using EdgeR, a negative binomial distribution of the count reads was the basis to select differentially expressed genes between miconazole treated and untreated samples at both time points, with a limited false discovery rate (FDR adjusted p-value <0.01).
Figure 1 Number of significant (overlapping) differentially expressed genes 4 h and 24 h after miconazole treatment. Using EdgeR, a negative binomial distribution of the count reads was the basis to select differentially expressed genes between miconazole treated and untreated samples at both time points, with a limited false discovery rate (FDR adjusted p-value <0.01).CC BY · PubMed Central
Figure 2 Distribution of major significantly overrepresented GO categories within the significantly up- or down-regulated gene lists at 4 h and 24 h post miconazole treatment, respectively. The percentages represent the relative amount of differentially expressed genes annotated to the respective GO category within the list of selected differentially expressed genes. Note that the sum of all represented GO categories in each pie chart is not equal to 100% since some genes belong to multiple GO categories and many of the differentially expressed genes are unannotated or annotated to GO categories that were not significantly overrepresented. Significant overrepresented GO categories were determined using the GO Term Finder at the Candida Genome Database (CGD) website (FDR adjusted p-value < 0.05).
Figure 2 Distribution of major significantly overrepresented GO categories within the significantly up- or down-regulated gene lists at 4 h and 24 h post miconazole treatment, respectively. The percentages represent the relative amount of differentially expressed genes annotated to the respective GO category within the list of selected differentially expressed genes. Note that the sum of all represented GO categories in each pie chart is not equal to 100% since some genes belong to multiple GO categories and many of the differentially expressed genes are unannotated or annotated to GO categories that were not significantly overrepresented. Significant overrepresented GO categories were determined using the GO Term Finder at the Candida Genome Database (CGD) website (FDR adjusted p-value < 0.05).CC BY · PubMed Central
Figure 3 Metabolic activity of C. albicans biofilms treated with a combination of miconazole and simvastatin, pyrithione zinc, CCCP, antimycin A and sodium azide. The control curve of miconazole alone is represented by diamonds, whereas combinations of miconazole with decreasing concentrations of other compound are indicated by circles, squares, triangles and reverted triangles. Data are mean ± SEM of five (n = 5) biologically independent experiments (each consisting of three repeats), determined with the metabolic activity dye CTB.
Figure 3 Metabolic activity of C. albicans biofilms treated with a combination of miconazole and simvastatin, pyrithione zinc, CCCP, antimycin A and sodium azide. The control curve of miconazole alone is represented by diamonds, whereas combinations of miconazole with decreasing concentrations of other compound are indicated by circles, squares, triangles and reverted triangles. Data are mean ± SEM of five (n = 5) biologically independent experiments (each consisting of three repeats), determined with the metabolic activity dye CTB.CC BY · PubMed Central
Figure 4 Number of cfus per C. albicans biofilm in the presence and absence of miconazole and/or (a) simvastatin, (b) pyrithione zinc, (c) antimycin A, (d) CCCP and (e) sodium azide. Black bars represent untreated biofilms or biofilms treated with 500 μM simvastatin, 20 μM pyrithione zinc, 25 μM antimycin A, 15.6 μM CCCP and 1,250 μM sodium azide alone while grey bars represent biofilms additionally treated with 125 μM miconazole. Data presented are the mean and SEM of at least three (n ≥ 3) independent experiments (each consisting of three replicates), measured by cfu counting. Two-way ANOVA statistical analysis with Tukey’s correction for multiple comparisons was performed to assign significant differences between treatments (* = p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Figure 4 Number of cfus per C. albicans biofilm in the presence and absence of miconazole and/or (a) simvastatin, (b) pyrithione zinc, (c) antimycin A, (d) CCCP and (e) sodium azide. Black bars represent untreated biofilms or biofilms treated with 500 μM simvastatin, 20 μM pyrithione zinc, 25 μM antimycin A, 15.6 μM CCCP and 1,250 μM sodium azide alone while grey bars represent biofilms additionally treated with 125 μM miconazole. Data presented are the mean and SEM of at least three (n ≥ 3) independent experiments (each consisting of three replicates), measured by cfu counting. Two-way ANOVA statistical analysis with Tukey’s correction for multiple comparisons was performed to assign significant differences between treatments (* = p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).CC BY · PubMed Central
Figure 5 Accumulation of superoxide radicals in Candida albicans biofilms in the presence and absence of miconazole and/or (a) simvastatin, (b) pyrithione zinc, (c) antimycin A, (d) CCCP and € sodium azide. Superoxide production is expressed as fluorescence per 1000 cfus assessed by cfu counting. Black bars represent untreated biofilms or biofilms treated with 500 μM simvastatin, 20 μM pyrithione zinc, 25 μM antimycin A, 15.6 μM CCCP and 1250 μM sodium azide only while grey bars represent biofilms additionally treated with 125 μM miconazole. Data presented are the mean and SEM of at least three (n ≥ 3) independent experiments (each consisting of three replicates). Two-way ANOVA statistical analysis with Tukey’s correction for multiple comparisons was performed to assign significant differences between all treatments (*p < 0.05, **p < 0.01).
Figure 5 Accumulation of superoxide radicals in Candida albicans biofilms in the presence and absence of miconazole and/or (a) simvastatin, (b) pyrithione zinc, (c) antimycin A, (d) CCCP and € sodium azide. Superoxide production is expressed as fluorescence per 1000 cfus assessed by cfu counting. Black bars represent untreated biofilms or biofilms treated with 500 μM simvastatin, 20 μM pyrithione zinc, 25 μM antimycin A, 15.6 μM CCCP and 1250 μM sodium azide only while grey bars represent biofilms additionally treated with 125 μM miconazole. Data presented are the mean and SEM of at least three (n ≥ 3) independent experiments (each consisting of three replicates). Two-way ANOVA statistical analysis with Tukey’s correction for multiple comparisons was performed to assign significant differences between all treatments (*p < 0.05, **p < 0.01).CC BY · PubMed Central
Figure 6 Involvement of superoxide dismutases in C. albicans biofilm tolerance to miconazole. (a) Percentage remaining biofilm cfus in wild type (CA-IF100) and triple sod mutant (ΔΔΔsod4sod5sod6) after treatment with 30 μM miconazole. A two-tailed paired Students t-test was performed to assign significant differences between the two strains (*p < 0.05). (b) Number of cfus per C. albicans SC5314 biofilm and (c) concomitant accumulation of superoxide radicals in the presence and absence of miconazole and/or DDC. Black bars represent untreated biofilms or biofilms treated with 10 mM DDC alone while grey bars represent biofilms additionally treated with 125 μM miconazole. Data presented are the mean and SEM of four (n = 4) independent experiments (each consisting of three replicates). Two-way ANOVA statistical analysis with Tukey’s correction for multiple comparisons was performed to assign significant differences between treatments (****p < 0.0001).
Figure 6 Involvement of superoxide dismutases in C. albicans biofilm tolerance to miconazole. (a) Percentage remaining biofilm cfus in wild type (CA-IF100) and triple sod mutant (ΔΔΔsod4sod5sod6) after treatment with 30 μM miconazole. A two-tailed paired Students t-test was performed to assign significant differences between the two strains (*p < 0.05). (b) Number of cfus per C. albicans SC5314 biofilm and (c) concomitant accumulation of superoxide radicals in the presence and absence of miconazole and/or DDC. Black bars represent untreated biofilms or biofilms treated with 10 mM DDC alone while grey bars represent biofilms additionally treated with 125 μM miconazole. Data presented are the mean and SEM of four (n = 4) independent experiments (each consisting of three replicates). Two-way ANOVA statistical analysis with Tukey’s correction for multiple comparisons was performed to assign significant differences between treatments (****p < 0.0001).CC BY · PubMed Central

Verification

Claims the paper makes

19 Valid · 0 Not valid · 23 Not checked · 94 Own results and interpretations

76 more claims

Create a free account to see all 136 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 34
  • It may state two separate claims as one. 30
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 77 references

Cited by

See all 34

Metadata

Authors
De Cremer, K., De Brucker, K., Staes, I., Peeters, A., Van den Driessche, F., Coenye, T., Cammue, B. P. A., & Thevissen, K.
Affiliations
  • KU Leuven (BE)
  • Ghent University (BE)
  • VIB-UGent Center for Plant Systems Biology (BE)
Corresponding author
Cammue, Bruno P. A.
Venue
Scientific Reports
Published
2016-06-07
Volume
6
Issue
1
Pages
27463-27463
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2418792487
Cited by
34
References
77
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 7 · 2020: 8 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 1
FWCI
3.08
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
  • Lirias (submittedVersion, other-oa)
Funders
  • Fonds Wetenschappelijk Onderzoek (12F0516N, WO.026.11N)
  • KU Leuven (IOF/m05/022)
  • Vlaamse regering
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Keywords
Candida albicans biofilm, miconazole, antifungal resistance, superoxide production, electron transport chain inhibitors, mitochondrial dysfunction, reactive oxygen species, sterol biosynthesis, drug efflux pumps, superoxide dismutase, N,N-diethyldithiocarbamate, whole transcriptome analysis
MeSH terms
Antifungal Agents, Candida albicans, Miconazole, Superoxides, Transcription, Genetic, Reactive Oxygen Species, Biofilms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.